Weather Disasters Impacted Counties With More Than 60 Percent of Drug Production Facilities
By Elana Gotkine HealthDay Reporter

FRIDAY, Aug. 22, 2025 -- More than 60 percent of drug production facilities were located in U.S. counties with at least one disaster declaration from 2019 to 2024, according to a research letter published online Aug. 20 in the Journal of the American Medical Association.
Mahnum Shahzad, Ph.D., from Harvard Medical School in Boston, and colleagues examined the frequency with which climate-related disaster events affected counties with U.S. drug production facilities. Counties with a Presidential Disaster Declaration from 2019 through 2024 were identified; the number of facilities that were in counties impacted by disasters was calculated.
Overall, there were 10,861 drug production facilities that were active from 2019 through 2024, ranging from 5,063 in 2023 to 8,790 in 2020 when 43.9 percent of the facilities were in counties with at least one disaster declaration. The researchers found 6,819 active facilities (62.8 percent) were located in counties where a disaster was declared, cumulatively, in the six-year period, with an average of 2,146 active facilities (33.8 percent) annually. During the study period, all types of climate-related disasters were declared in at least one county with an active drug production facility, with hurricanes the most common. The likelihood that counties with and without drug production facilities experienced at least one disaster declaration did not differ significantly.
"These findings underscore the importance of recognizing climate-related vulnerabilities and the urgent need for supply chain transparency, for strategic allocation of production, and for disaster risk management strategies to prevent health care disruptions in the United States," the authors write.
One author disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-23 06:00
Read more

- Insulin Nasal Spray Reaches Alzheimer's Targets, Brain Scans Show
- Patients With Diabetes More Likely to Experience Adverse Financial Outcomes
- Low Vitamin D Levels Up Risk for COVID-19 Hospitalization
- Sobi Announces U.S. Food and Drug Administration Approves Doptelet (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
- Semaglutide Not Linked to Increased Risk of Eye Disorders, Diabetic Retinopathy
- Public Believes Dermatologic Side Effects From Cancer Treatment Are Common
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions